Photo of Adam Herbst

Adam Herbst is a partner in the Governmental Practice in the firm's New York office. He is also a member of the Healthcare Team.

New York State has a long-standing commitment to supporting its most vulnerable populations through Medicaid-funded services for older adults and those requiring long-term care. However, rising costs and an increasingly complex healthcare landscape have created challenges that demand innovative solutions. As New York seeks to align its healthcare system with evolving needs, the time has come to adopt integrated care models that promote sustainability, efficiency, and improved outcomes.Continue Reading Building a Smarter Long-Term Care System in New York

Navigating the Certificate of Need (CON) process in New York is no small task. It’s a critical gateway for healthcare providers, particularly in the long-term care sector, to establish, expand, or modify services. The laws and regulations governing this process—rooted in Articles 28, 36, and 40 of New York’s Public Health Law—are complex, ever-evolving, and often overwhelming for even the most seasoned professionals.Continue Reading Inside the World of Long-Term Care Certificate of Need (CON): An Exclusive Opportunity

I’m honored to participate in the University of Miami’s Business of Health Care Conference on January 24, 2025. This highly anticipated event brings together leaders from the nation’s most influential health care organizations to discuss the evolving health care landscape under the incoming administration.Continue Reading Health Care at a Crossroads: Insights from the Post-Election Health Care Conference

The rising cost of prescription drugs under Medicare continues to pose significant challenges for seniors, a population that relies heavily on consistent and affordable access to medications. This issue underscores broader gaps in the healthcare system and highlights the critical need for legal, regulatory, and economic strategies that prioritize aging populations.Continue Reading The Legal and Economic Realities of Medicare Drug Pricing: Navigating Opportunities and Challenges